Redpoint Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,985
| Closed | -$384K | – | 614 |
|
|
2022
Q1 | $384K | Buy |
4,985
+394
| +9% | +$30.4K | 0.04% | 497 |
|
|
2021
Q4 | $406K | Hold |
4,591
| – | – | 0.03% | 500 |
|
|
2021
Q3 | $355K | Hold |
4,591
| – | – | 0.03% | 531 |
|
|
2021
Q2 | $383K | Hold |
4,591
| – | – | 0.03% | 522 |
|
|
2021
Q1 | $347K | Hold |
4,591
| – | – | 0.03% | 536 |
|
|
2020
Q4 | $403K | Hold |
4,591
| – | – | 0.04% | 413 |
|
|
2020
Q3 | $349K | Sell |
4,591
-366
| -7% | -$27.8K | 0.04% | 439 |
|
|
2020
Q2 | $611K | Buy |
4,957
+1,182
| +31% | +$146K | 0.03% | 413 |
|
|
2020
Q1 | $319K | Hold |
3,775
| – | – | 0.02% | 453 |
|
|
2019
Q4 | $319K | Hold |
3,775
| – | – | 0.02% | 508 |
|
|
2019
Q3 | $254K | Buy |
3,775
+642
| +20% | +$43.2K | 0.01% | 528 |
|
|
2019
Q2 | $268K | Hold |
3,133
| – | – | 0.01% | 530 |
|
|
2019
Q1 | $278K | Hold |
3,133
| – | – | 0.01% | 523 |
|
|
2018
Q4 | $267K | Hold |
3,133
| – | – | 0.02% | 504 |
|
|
2018
Q3 | $304K | Hold |
3,133
| – | – | 0.02% | 503 |
|
|
2018
Q2 | $295K | Hold |
3,133
| – | – | 0.02% | 462 |
|
|
2018
Q1 | $254K | Hold |
3,133
| – | – | 0.01% | 477 |
|
|
2017
Q4 | $279K | Buy |
+3,133
| New | +$279K | 0.02% | 466 |
|